NeueHealth, Inc. (NEUE)
Oct 2, 2025 - NEUE was delisted (reason: taken private)
6.75
+0.08 (1.24%)
Inactive · Last trade price on Oct 1, 2025
NeueHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 887.99 | 935.61 | 1,161 | 806.59 | 1,513 | 514.89 | |
Revenue Growth (YoY) | -14.04% | -19.39% | 43.90% | -46.69% | 193.86% | 89.07% |
Cost of Revenue | 674.89 | 742.14 | 996.58 | 662.97 | 1,294 | 451.92 |
Gross Profit | 213.1 | 193.47 | 164.13 | 143.62 | 218.88 | 62.97 |
Selling, General & Admin | 230.4 | 273.91 | 314.55 | 354.45 | 527.45 | 225.06 |
Depreciation & Amortization Expenses | 14.22 | 15.65 | 18.3 | 30.71 | 35.05 | 8.29 |
Other Operating Expenses | 0.78 | 12.37 | 408.38 | 71.79 | - | - |
Total Operating Expenses | 245.39 | 301.93 | 741.22 | 456.95 | 562.5 | 233.35 |
Operating Income | -32.29 | -108.45 | -577.08 | -313.33 | -343.63 | -170.38 |
Interest Income | 2.45 | 1.04 | 0.09 | -55.43 | - | - |
Interest Expense | -25.18 | -18.7 | -38.2 | -12.82 | -7.23 | - |
Other Non-Operating Income (Expense) | 5.86 | 33.97 | 13.97 | - | 1.23 | - |
Total Non-Operating Income (Expense) | -16.87 | 16.32 | -24.15 | -68.25 | -6 | - |
Pretax Income | -60.88 | -99.46 | -629.17 | -381.58 | -349.63 | -170.38 |
Provision for Income Taxes | 2.21 | 2.6 | -1.43 | 3.66 | -26.52 | -9.16 |
Net Income | -63.09 | -102.06 | -627.74 | -385.24 | -323.11 | -161.22 |
Minority Interest in Earnings | 31.69 | 34.96 | -114.35 | 95.66 | 6.5 | - |
Net Income Attributable to Preferred Dividends | 52.87 | 51.65 | 49.15 | 39.69 | - | - |
Earnings From Discontinued Operations | 12.85 | 2.34 | -638.07 | -974.64 | -855.26 | -87.22 |
Net Income to Common | -134.8 | -186.33 | -1,201 | -1,495 | -1,185 | -248.44 |
Shares Outstanding (Basic) | 9 | 8 | 8 | 8 | 5 | 2 |
Shares Outstanding (Diluted) | 9 | 8 | 8 | 8 | 5 | 2 |
Shares Change (YoY) | 5.56% | 3.42% | 1.09% | 60.47% | 188.00% | 1.27% |
EPS (Basic) | -12.20 | -22.65 | -150.94 | -190.04 | -67.20 | -94.40 |
EPS (Diluted) | -12.20 | -22.65 | -150.94 | -190.04 | -67.20 | -94.40 |
Free Cash Flow | -74.05 | -125.55 | -2,729 | 207.02 | 51.65 | -63.71 |
Free Cash Flow Growth | - | - | - | 300.85% | - | - |
Free Cash Flow Per Share | -8.70 | -15.26 | -343.15 | 26.31 | 10.53 | -37.42 |
Gross Margin | 24.00% | 20.68% | 14.14% | 17.81% | 14.47% | 12.23% |
Operating Margin | -3.64% | -11.59% | -49.72% | -38.85% | -22.71% | -33.09% |
Profit Margin | -7.10% | -10.91% | -54.08% | -47.76% | -21.36% | -31.31% |
FCF Margin | -8.34% | -13.42% | -235.15% | 25.67% | 3.41% | -12.37% |
EBITDA | -18.07 | -92.81 | -552.92 | -262.75 | -308.14 | -162.09 |
EBITDA Margin | -2.04% | -9.92% | -47.64% | -32.58% | -20.37% | -31.48% |
EBIT | -32.29 | -108.45 | -577.08 | -313.33 | -343.63 | -170.38 |
EBIT Margin | -3.64% | -11.59% | -49.72% | -38.85% | -22.71% | -33.09% |
Effective Tax Rate | -3.63% | -2.61% | 0.23% | -0.96% | 7.59% | 5.38% |